KR101191682B1 - 에폭시부탄올 중간체의 제조 방법 - Google Patents

에폭시부탄올 중간체의 제조 방법 Download PDF

Info

Publication number
KR101191682B1
KR101191682B1 KR1020087015976A KR20087015976A KR101191682B1 KR 101191682 B1 KR101191682 B1 KR 101191682B1 KR 1020087015976 A KR1020087015976 A KR 1020087015976A KR 20087015976 A KR20087015976 A KR 20087015976A KR 101191682 B1 KR101191682 B1 KR 101191682B1
Authority
KR
South Korea
Prior art keywords
formula
compound
hal
same meaning
prg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020087015976A
Other languages
English (en)
Korean (ko)
Other versions
KR20080075014A (ko
Inventor
마르끄 뮐레
린 수
Original Assignee
바실리어 파마슈티카 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바실리어 파마슈티카 아게 filed Critical 바실리어 파마슈티카 아게
Publication of KR20080075014A publication Critical patent/KR20080075014A/ko
Application granted granted Critical
Publication of KR101191682B1 publication Critical patent/KR101191682B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/08Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
KR1020087015976A 2005-12-01 2006-11-29 에폭시부탄올 중간체의 제조 방법 Active KR101191682B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05026163.5 2005-12-01
EP05026163 2005-12-01
PCT/CH2006/000671 WO2007062542A2 (en) 2005-12-01 2006-11-29 Process for the manufacture of epoxybutanol intermediates

Publications (2)

Publication Number Publication Date
KR20080075014A KR20080075014A (ko) 2008-08-13
KR101191682B1 true KR101191682B1 (ko) 2012-10-16

Family

ID=36178579

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087015976A Active KR101191682B1 (ko) 2005-12-01 2006-11-29 에폭시부탄올 중간체의 제조 방법

Country Status (19)

Country Link
US (2) US7816537B2 (enExample)
EP (2) EP1954264B1 (enExample)
JP (1) JP5329969B2 (enExample)
KR (1) KR101191682B1 (enExample)
CN (1) CN101321522B (enExample)
AT (1) ATE444747T1 (enExample)
AU (2) AU2006319657B2 (enExample)
BR (1) BRPI0619120B1 (enExample)
CA (2) CA2711852C (enExample)
CY (1) CY1110588T1 (enExample)
DE (1) DE602006009698D1 (enExample)
DK (1) DK1954264T3 (enExample)
ES (1) ES2333258T3 (enExample)
HR (1) HRP20090675T1 (enExample)
PL (1) PL1954264T3 (enExample)
PT (1) PT1954264E (enExample)
SI (1) SI1954264T1 (enExample)
WO (1) WO2007062542A2 (enExample)
ZA (1) ZA200804218B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5767643B2 (ja) 2009-09-21 2015-08-19 ギリード・サイエンシズ・インコーポレーテッド 1’−置換カルバヌクレオシド類似体の調製のためのプロセスおよび中間体
PE20130400A1 (es) 2010-07-22 2013-04-10 Gilead Sciences Inc Metodos y compuestos para tratar infecciones virales por paramyxoviridae
JP6334529B2 (ja) 2012-08-07 2018-05-30 バジリア ファルマスーチカ アーゲーBasilea Pharmaceutica AG イサブコナゾールまたはラブコナゾールの製造方法
WO2015150947A1 (en) 2014-03-29 2015-10-08 Wockhardt Limited A process for the preparation of isavuconazole and its intermediates
TWI698444B (zh) 2014-10-29 2020-07-11 美商基利科學股份有限公司 製備核糖苷的方法
PT3349758T (pt) 2015-09-16 2022-07-13 Gilead Sciences Inc Métodos para o tratamento de infeções pelo vírus arenaviridae
CN105367528A (zh) * 2015-11-10 2016-03-02 南通诺泰生物医药技术有限公司 一种三唑类药物中间体(d)-1-(1-环烷仲胺基)-2-(2-四氢吡喃基)氧-1-丙酮类化合物及合成方法
CN110869028B (zh) 2017-03-14 2023-01-20 吉利德科学公司 治疗猫冠状病毒感染的方法
KR20190141747A (ko) 2017-05-01 2019-12-24 길리애드 사이언시즈, 인코포레이티드 (S)-2-에틸부틸 2-(((S)-(((2R,3S,4R,5R)-5-(4-아미노피롤로[2,1-f] [1,2,4]트리아진-7-일)-5-시아노-3,4-디히드록시테트라히드로푸란-2-일)메톡시)(페녹시) 포스포릴)아미노)프로파노에이트의 결정질 형태
US10675296B2 (en) 2017-07-11 2020-06-09 Gilead Sciences, Inc. Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
SG11201911637QA (en) 2017-08-10 2020-01-30 Sumitomo Chemical Co Process for producing epoxy alcohol compound
CN118766947A (zh) 2020-01-27 2024-10-15 吉利德科学公司 用于治疗SARS CoV-2感染的方法
CA3169340A1 (en) 2020-03-12 2021-09-16 Pavel R. Badalov Methods of preparing 1'-cyano nucleosides
JP7482250B2 (ja) 2020-04-06 2024-05-13 ギリアード サイエンシーズ, インコーポレイテッド 1’-シアノ置換カルバヌクレオシド類似体の吸入製剤
PL4157272T3 (pl) 2020-05-29 2025-10-20 Gilead Sciences, Inc. Remdesiwir do leczenia zakażeń wirusowych
JP2023531524A (ja) 2020-06-24 2023-07-24 ギリアード サイエンシーズ, インコーポレイテッド 1’-シアノヌクレオシド類似体及びその使用
LT4204421T (lt) 2020-08-27 2024-06-25 Gilead Sciences, Inc. Virusinių infekcijų gydymui skirti junginiai ir būdai
US20230295172A1 (en) 2022-03-02 2023-09-21 Gilead Sciences, Inc. Compounds and methods for treatment of viral infections
CN115536643A (zh) * 2022-12-05 2022-12-30 南京桦冠生物技术有限公司 一种艾沙康唑类药物关键中间体的制备方法
US12357577B1 (en) 2024-02-02 2025-07-15 Gilead Sciences, Inc. Pharmaceutical formulations and uses thereof
CN119264078B (zh) * 2024-12-09 2025-08-01 浙江世佳科技股份有限公司 一种(5s,6r)-5,6-环氧-2-十七碳炔-1-醇的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3452213B2 (ja) * 1994-07-05 2003-09-29 エーザイ株式会社 抗真菌剤及びその製造方法
WO1999045008A1 (en) * 1998-03-06 1999-09-10 F. Hoffmann-La Roche Ag 3-[4-(4-cyanophenyl)thiazol-2-y)]-1-(1h-1,2,4-triazol-1-yl)-butan-2-ol derivatives having antifungal activity
US6133485A (en) * 1998-04-15 2000-10-17 Synphar Laboratories, Inc. Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
US6391903B1 (en) * 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
US6884892B2 (en) * 2002-06-20 2005-04-26 Sumitomo Chemical Company, Limited Production methods of epoxytriazole derivative and intermediate therefor
JP4627413B2 (ja) * 2003-05-06 2011-02-09 三井化学株式会社 1−アゾール−2−フェニル−2、3−プロパンジオール誘導体の製造法

Also Published As

Publication number Publication date
PL1954264T3 (pl) 2010-02-26
CA2711852A1 (en) 2007-06-07
WO2007062542A3 (en) 2007-11-01
WO2007062542A2 (en) 2007-06-07
CA2629092A1 (en) 2007-06-07
ATE444747T1 (de) 2009-10-15
HRP20090675T1 (hr) 2010-01-31
US20110021794A1 (en) 2011-01-27
JP5329969B2 (ja) 2013-10-30
US7816537B2 (en) 2010-10-19
BRPI0619120B1 (pt) 2023-10-10
DE602006009698D1 (de) 2009-11-19
CN101321522B (zh) 2012-05-30
PT1954264E (pt) 2009-12-23
KR20080075014A (ko) 2008-08-13
CA2711852C (en) 2011-10-04
EP2133345A1 (en) 2009-12-16
AU2010203301B2 (en) 2012-06-21
EP1954264A2 (en) 2008-08-13
ES2333258T3 (es) 2010-02-18
AU2006319657B2 (en) 2010-08-12
BRPI0619120A2 (pt) 2011-09-13
AU2006319657A1 (en) 2007-06-07
CN101321522A (zh) 2008-12-10
AU2010203301A1 (en) 2010-08-12
EP1954264B1 (en) 2009-10-07
SI1954264T1 (sl) 2010-01-29
CY1110588T1 (el) 2015-04-29
ZA200804218B (en) 2009-01-28
US8076494B2 (en) 2011-12-13
JP2009517413A (ja) 2009-04-30
DK1954264T3 (da) 2010-01-11
US20090299073A1 (en) 2009-12-03
CA2629092C (en) 2012-01-03

Similar Documents

Publication Publication Date Title
KR101191682B1 (ko) 에폭시부탄올 중간체의 제조 방법
JP2009517413A5 (enExample)
US6809223B2 (en) Process for stereoselective synthesis of prostacyclin derivatives
JP4336648B2 (ja) エポキシトリアゾール誘導体およびその中間体の製造方法
RU2656600C2 (ru) Способ получения производного фторлактона
US6133485A (en) Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
JP2002511434A5 (enExample)
EP1693358B1 (en) Process for producing epoxytriazole compound and intermediate therefor
JP4330898B2 (ja) 光学活性2−フェニル−2,3−ジヒドロキシプロピルアゾール誘導体の製造法
KR101285483B1 (ko) 광학 활성 4,4-2치환 옥사졸리딘 유도체와 그 제조 방법
KR20160126700A (ko) 스타틴의 중간체, 이의 제조방법 및 이를 이용한 로수바스타틴의 제조방법
JP2020529412A (ja) 中間体化合物及び方法
CZ86799A3 (cs) Způsob výroby substituovaných derivátů chromanolu a meziprodukty pro tyto způsoby

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080630

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20100325

Comment text: Request for Examination of Application

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20111102

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20120829

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20121010

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20121010

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20150918

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20150918

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20161010

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20161010

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20170921

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20170921

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20180827

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20190809

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20190809

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20200814

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20210813

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20220823

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20240823

Start annual number: 13

End annual number: 13